Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
International Journal of Geriatric Psychiatry · 2023-02 · 38 (2)
DOI: 10.1002/gps.5882 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Geriatric Psychiatry, online erschienen am 05.02.2023. Verfasst von Krista L Lanctôt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Psychiatry and of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Apathy, Alzheimer Disease. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIA NIH HHS, Cerevel Therapeutics.
Themen: Depression
Abstract (Originalsprache)
Objectives
This narrative review describes the clinical features of apathy and depression in individuals with neurocognitive disorders (NCDs), with the goal of differentiating the two syndromes on the basis of clinical presentation, diagnostic criteria, neuropathological features, and contrasting responses to treatments.
Methods
Literature was identified using PubMed, with search terms to capture medical conditions of interest; additional references were also included based on our collective experience and knowledge of the literature.
Results
Evidence from current literature supports the distinction between the two disorders; apathy and depression occur with varying prevalence in individuals with NCDs, pose different risks of progression to dementia, and have distinct, if overlapping, neurobiological underpinnings. Although apathy is a distinct neuropsychiatric syndrome, distinguishing apathy from depression can be challenging, as both conditions may occur concurrently and share several overlapping features. Apathy is associated with unfavorable outcomes, especially those with neurodegenerative etiologies (e.g., Alzheimer's disease) and is associated with an increased burden for both patients and caregivers. Diagnosing apathy is important not only to serve as the basis for appropriate treatment, but also for the development of novel targeted interventions for this condition. Although there are currently no approved pharmacologic treatments for apathy, the research described in this review supports apathy as a distinct neuropsychiatric condition that warrants specific treatments aimed at alleviating patient disability.
Conclusions
Despite differences between these disorders, both apathy and depression pose significant challenges to patients, their families, and caregivers; better diagnostics are needed to develop more tailored treatment and support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Psychiatry and of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
- Neuropsychopharmacology Research Group, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
- Bernick Chair in Geriatric Psychopharmacology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences, Hotchkiss Brain Institute, O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada.
- Department of Brain Health, Chambers-Grundy Center for Transformative Neuroscience, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV), Las Vegas, Nevada, USA.
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
ORCID-Profile: Krista L Lanctôt, Jeffrey L Cummings
Förderung
- NIGMS NIH HHS
- NIA NIH HHS
- Cerevel Therapeutics
Zitieren
APA
Lanctôt, K. L., Ismail, Z., Bawa, K. K., Cummings, J. L., Husain, M., Mortby, M. E., & Robert, P. (2023). Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders. International Journal of Geriatric Psychiatry, 38(2). https://doi.org/10.1002/gps.5882
Vancouver
Lanctôt KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, et al. Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders. International Journal of Geriatric Psychiatry. 2023;38(2). doi:10.1002/gps.5882
BibTeX
@article{Lanctt2023,
author = {Lanctôt, Krista L and Ismail, Zahinoor and Bawa, Kritleen K and Cummings, Jeffrey L and Husain, Masud and Mortby, Moyra E and Robert, Philippe},
title = {Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders},
journal = {International Journal of Geriatric Psychiatry},
year = {2023},
volume = {38},
number = {2},
doi = {10.1002/gps.5882}
}
EUVIMED